For instance, the CBX4 rs2289728 (G>A) SNP has been linked to a decreased risk of hepatocellular carcinoma (HCC), potentially by reducing CBX4 expression and alleviating repression of tumor suppressor genes like cyclin-dependent kinase inhibitor 2A (CDKN2A). Here, CDKN2A is linked to hepatocellular carcinoma.